Research highlights novel gene therapy delivery

Project aims to scale production of induced plur

Longevity company builder Maximon spawns new ven

TimePie’s Hebe Chen spotlights the upcoming fi

Company eyes GLP-1 combination potential for ‘

A new study indicates that potassium isotope ana

Ahead of his appearance at Longevity Investors C

Food for the Brain develops pin-prick test that

New wellness brand introduces products inspired

Company targets organ transplant shortage after

Longevity biotech to become sector’s next publ

Company readies for Phase 2 studies after fronto

Berlin startup focuses on ‘whole genome’ ana

Australian-led research project lands $11.

Nadine Esposito on why focusing on finance and c

Study shows semaglutide has ‘far-reaching bene

Platform integrates health data from hundreds of

Cellular rejuvenation company aims to advance ne

Aging drug discovery conference demonstrates tha

Highly anticipated conference returns to Switzer

Companies file joint patents relating to synergi

Collaboration between LT, Founders Forum and NUS

Targeting inflammatory diseases, company gears u

As ARDD gets underway, Life Bio’s CEO explains

DdrC protein repairs broken DNA fragments, resto

Mary Lou Jepsen’s latest $100m venture leverag

More than 160 speakers to present as the world’s largest aging drug discovery conference opens its doors. In the glorious settings of The University of Copenhagen, the largest conference on aging in the biopharmaceutical industry kicks off its proceedings today, beginning a full week of sessions, speakers and workshops. The 11th annual Aging Research and Drug Discovery conference (ARDD) once again brings together the world’s leading authorities on the science of aging and how to target the aging process in humans to enable healthier and longer lives for all. In addition to ARDD’s always stellar academic lineup, the 2024 conference boasts an incredibly strong presence from leading biotech companies in the aging field, further boosted by the presence of pharma companies including Lilly, Lundbeck, Novartis, Regeneron and others. Another significant focus of this year’s event is on longevity medicine, with an entire track dedicated to the translation from basic science towards the clinic and the implications for practicing physicians. ARDD’s home is in Denmark at the University of Copenhagen. Alongside Insilico Medicine boss Alex Zhavoronkov, ARDD is chaired by University of Copenhagen professors Morten Scheibye-Knudsen and Daniela Bakula. “I’m extremely happy about the program – we have an incredible lineup…

Victoria Forest on how a new longevity city in G

ALZpath CEO on building a scalable Alzheimer’s

Veteran pharmaceutical executive Jean-Pierre Gar

Company intends to expand its network of longevi

Finnish company claims its test is the first to

Investment will fund VNA-318, Vandria’s lead t

Company taps into Pfizer’s Boulder team as it

New data-powered digital health platform Thrive

New research reveals that certain antidiabetic d

Precision-fermented version of lactoferrin is li

Amid increasing concern over the validity of lon

MIT spinout leverages single strand DNA to ‘br

New clinical trial suggests donor stem cell trea

Company targets US metabolic health crisis, rais

Stanford Medicine study reveals we experience tw

Treating Alzheimer’s patients with combination

When you use links on our website, we may earn a f

The 11th ARDD conference will feature a star-stu

Topical treatment is designed to reactivate dorm

José Cordeiro and Felix Werth explore how the d

Genetic testing firm closes drug discovery divis

Researchers develop new method to create complex

Partnership aims to bring C2N’s portfolio of A